Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (441-450 of 545) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
High-dose cisplatin with sodium thiosulfate protectionC E Pfeifle, S B Howell, R D Felthouse, et al.
Molecular and Cellular Biology|March 6, 1998
Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouseV Korinek, N Barker, K Willert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.
Cancer Research|December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trialD Fennelly, C Wasserheit, J Schneider, et al.
Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapyK M Zanotti, L A Rybicki, A W Kennedy, et al.
Circulation|March 17, 2020
Trends in Antiarrhythmic Drug Use Among Patients in the United States Between 2004 and 2016Timothy M Markman, Zhi Geng, Andrew E Epstein, et al.
Pageof 55

Showing results (441-450 of 545) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
High-dose cisplatin with sodium thiosulfate protectionC E Pfeifle, S B Howell, R D Felthouse, et al.
Molecular and Cellular Biology|March 6, 1998
Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouseV Korinek, N Barker, K Willert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.
Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.
Cancer Research|December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trialD Fennelly, C Wasserheit, J Schneider, et al.
Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapyK M Zanotti, L A Rybicki, A W Kennedy, et al.
Circulation|March 17, 2020
Trends in Antiarrhythmic Drug Use Among Patients in the United States Between 2004 and 2016Timothy M Markman, Zhi Geng, Andrew E Epstein, et al.
Pageof 55